Neuroprotective Therapy Company Quethera Reveals Gene Therapy Results at ARVO
Quethera, a biopharmaceutical company developing therapies for ocular disorders
Rainbow announce funding investment in Nemesis Bioscience
Cytox Plans US Clinical Launch for Early-Stage Alzheimer's Test While Courting Pharma Partners
Helping to Maximise the Economic Impact of the UK's Scientific Research
We work with our partners to turn the UK's world class research into global products and services.
Rainbow & Innovate UK partner to fund infrastructure systems and health and life sciences growth companies
Bio-start announce the 15 companies joining the first UK's synthetic biology accelerator programme
Andrew Seedhouse is Chief Technology Office for Rainbow Partner DSTL and Head of The Centre for Defence Enterprise.